Results 291 to 300 of about 279,189 (378)

Novel Animal Model of Enterobacteria Pathogenicity, Virulence, and Amoxicillin—Biosurfactant Synergic Using Nsombé (Rhynchophorus phoenicis Larvae)

open access: yesMicrobiologyOpen, Volume 14, Issue 4, August 2025.
This study highlights the potential of Rhynchophorus phoenicis larvae as an alternative infection model for evaluating host–pathogen interactions and the synergistic effects of combined antimicrobial therapies using antibiotics and biosurfactants. ABSTRACT Insect larvae are increasingly being employed as sophisticated infection models in the expanding ...
Sergy Patrick Junior Bissoko   +5 more
wiley   +1 more source

Modeling, virtual screening, and enzymatic docking of trehalose 6‐phosphate phosphatase and evaluation of the insecticidal effect of phthalimide, N‐(p‐tolylsulfonyl) on Aedes aegypti (Diptera: Culicidae)

open access: yesPest Management Science, Volume 81, Issue 8, Page 4777-4787, August 2025.
Schematic diagram of the experimental procedures used to perform the bioinformatic steps and insecticidal assays using trehalose 6‐phosphate phosphatase of Aedes aegypti and the molecule phthalimide, N‐(p‐tolylsulfonyl). Abstract BACKGROUND Aedes aegypti Linnaeus is a medically important vector because of its role in transmitting several arboviruses ...
Raquel Jemima Viana Lima   +3 more
wiley   +1 more source

Revisiting steroidal glycoalkaloids as hatching stimulants for Globodera rostochiensis and Globodera pallida

open access: yesPest Management Science, Volume 81, Issue 8, Page 4848-4862, August 2025.
Structural differences in steroidal glycoalkaloids (SGAs) differentially stimulate hatching in Globodera rostochiensis and Globodera pallida, triggering distinct gene expression responses. These findings offer insights into species‐specific hatching mechanisms, advancing the development of more targeted strategies for managing potato cyst nematode ...
Andrea Caroline Ruthes   +2 more
wiley   +1 more source

Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine

open access: yesFASEB BioAdvances, Volume 7, Issue 8, August 2025.
Plasmalogens are specialized lipids affecting the membrane structure, dynamics, and key cell signaling pathways. They protect cells from oxidative damage. Plasmalogen deficiency is associated with severe diseases. Lipid nanoparticles and nanomedicine offer unexplored therapeutic potential for restoring plasmalogen levels under pathological conditions ...
Yu Wu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy